NASDAQ: GOVX
GeoVax Labs, Inc.
Healthcare · Biotechnology
After hours: $0.74(+3.06%) · as of 7:52 PM ET
Market Cap
$5.29M
52w High
$20.00
52w Low
$0.64
P/E
-0.05
Volume
196.93K
Outstanding Shares
7.37M
Performance
Return analysis
Price vs Fundamentals
Why The Stock Is Moving
What changed
The stock fell 96.17% over the last year. Revenue declined 100% over the trailing twelve months. Free cash flow grew 32.95% over the trailing twelve months.
What the market seems to be pricing
The stock has moved lower against modestly weakening underlying metrics. The operating data does not yet tell a clear story — the move may reflect sentiment, sector rotation, or macro factors rather than company-specific earnings power.
What would invalidate this read
A decisive move in revenue — currently down 100% — would be the clearest signal to resolve the ambiguity.
Company profile
GeoVax Labs, Inc. is a biotechnology company in the clinical development phase, focused on creating innovative human vaccines and immunotherapies.
Valuation
Stock splits
Every 25 shares became 1
Every 15 shares became 1
Every 20 shares became 1
Every 2000 shares became 1
Every 500 shares became 1
Every 50 shares became 1
Profitability & growth
Analyst consensus
6
Buy
1
Hold
0
Sell
Analyst ratings tend to be lagging indicators. Use as one signal among many.
Earnings
Full quarter-by-quarter history of actuals vs estimates. Switch into compare mode to inspect one metric year-over-year.
Next report
Nov 12, 2026
Q4 FY26 · EPS est -$1.03 · Revenue est —
View